BioMoti Company

BioMoti seeks to transform the treatment of cancer by targeted delivery of therapeutics to the intracellular space of cancer cells
Technology: Small Molecules
Industry: PharmTech
Headquarters: London, England, United Kingdom
Founded Date: 2006
Employees Number: 1-10
Funding Status: Seed
Estimated Revenue: Less than $1M

Visit Website
http://twitter.com/biomotiCEO
Register and Claim Ownership